CCTG SC28 SEAMLESS study is now open in Canada

The CCTG SC28 SEAMLESS study is now open in Canada for anyone who has completed their primary cancer treatment, to learn mindfulness meditation on an app and see if it helps to improve stress and well being.

"People who have had cancer may have multiple unmet psychosocial needs after the completion of their primary treatment, and for the first 5 years of surveillance and follow-up. Survivors often report feeling “lost in transition” as they shift back to their previous lives at home and in the workplace," says study chair Dr. Linda Ellen Carlson, Tom Baker Cancer Centre.

The purpose of this study is to test if a mindfulness program (Mindfulness Based Cancer Survivorship (MBCS) Journey) delivered through a mobile Am Mindfulness smartphone application can reduce ongoing psychosocial symptoms such as stress, anxiety, depression, fatigue, and fear of cancer recurrence or progression that are often experienced by survivors. The study involves using the app daily for four weeks and can be done totally remotely from one's own home, anywhere in Canada

There is a need for more accessible approaches to delivering psychosocial care after completion of primary treatment to ensure the growing population of survivors experience a better quality of life and improved health outcomes.

For more information visit:

• SC28 members trial page
• SC28 patient information page
• SC28 NCT05470010 on www.clinicaltrials.gov